Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Penn State receives $1.6 million grant to study the link between COVID-19 and cognitive decline

As populations around the globe age, dementia - often caused by Alzheimer's disease and related disorders - is a growing health issue for older adults worldwide.

26 Aug 2022

UC Davis research reveals a novel role for how tau functions in healthy nerve cells

In Alzheimer's Disease and other neurodegenerative dementias, proteins that normally play a role in healthy brain tissue turn bad, clumping together to form insoluble plaques and tangles as neurons wither and die.

25 Aug 2022

Study investigates associations between MS prevalence and factors driving regional differences

Researchers have known people who live farther from the equator are more likely to develop multiple sclerosis (MS) and have often attributed that to vitamin D exposure.

24 Aug 2022

Changes in brain connections occur very early in Alzheimer's disease

Although a lot is known about brain alterations in symptomatic Alzheimer's disease (AD), less is known about changes in the brain network early in the disease process.

24 Aug 2022

Study analyzes associations between BMI and dementia in older women and men

A substantial body of literature has analyzed the potential association between late-life body mass index (BMI) and dementia.

24 Aug 2022

Simple blood test can accurately detect Alzheimer's disease in people with Down syndrome

Around 80% of people with Down syndrome develop Alzheimer's disease, often when they are between 40 and 50 years old.

24 Aug 2022

Study provides evidence of a new form of dementia affecting WTC responders

A study that assessed the brains of 99 World Trade Center (WTC) responders by using diffusion tractography, a 3-D imaging technique, showed that WTC responders with cognitive impairment (CI), a possible sign of dementia, and post-traumatic stress disorder (PTSD), have a different presentation of the white matter in their brains compared to responders with CI without PTSD.

23 Aug 2022

Brain cells with the same birthdate show distinct connectivity and activity, study finds

Brain cells with the same "birthdate" are more likely to wire together into cooperative signaling circuits that carry out many functions, including the storage of memories, a new study finds.

22 Aug 2022

Sanders-Brown director receives $1.5 million grant to advance research on Alzheimer's treatment

Linda J. Van Eldik, Ph.D., director of the University of Kentucky Sanders-Brown Center on Aging, is part of a $1.5 million grant to help further research into a possible treatment for Alzheimer's disease.

19 Aug 2022

Increasing the production of new neurons rescues memory defects in mice with Alzheimer's disease

Researchers at the University of Illinois Chicago have discovered that increasing the production of new neurons in mice with Alzheimer's disease (AD) rescues the animals' memory defects.

19 Aug 2022

Alzheimer's disease disrupts visual memory by degrading cross-hemispheric cells

A new MIT study finds that Alzheimer's disease disrupts at least one form of visual memory by degrading a newly identified circuit that connects the vision processing centers of each brain hemisphere.

19 Aug 2022

Combination of new testing methods helps identify multiple dementia risk genes

A new UCLA-led study has identified multiple new risk genes for Alzheimer's disease and a rare, related brain disorder called progressive supranuclear palsy (PSP) by using a combination of new testing methods allowing for mass screening of genetic variants in a single experiment.

18 Aug 2022

Therapeutic target for several metabolic diseases may help fight Alzheimer’s disease

In the recent popular Korean TV series "The Light in Your Eyes," many viewers emphasized with the main character suffering from Alzheimer's disease.

18 Aug 2022

Women with epilepsy have more depression and anxiety symptoms during pregnancy and postpartum

Pregnant women with epilepsy have more symptoms of depression and anxiety during pregnancy and postpartum than pregnant women who do not have epilepsy or women with epilepsy who are not pregnant, according to a study published in the August 17, 2022, online issue of Neurology, the medical journal of the American Academy of Neurology.

17 Aug 2022

Study reveals a mechanism linking DDT exposure to Alzheimer's disease

A new study led by researchers from Florida International University (FIU) reveals a mechanism linking the pesticide DDT to Alzheimer's disease.

17 Aug 2022

Expert panel identifies critical challenges in recruiting study participants

Unless cures are found, Alzheimer's dementia is projected to affect nearly 13 million Americans by 2050 - overwhelming families, caregivers and our healthcare system. Yet only one new therapeutic, aducanumab, has come to market in the past 20 years, and therapeutic progress remains hampered for several reasons: recruiting study participants in clinical trials for Alzheimer's is more challenging than other disease areas, the trials take longer to complete and they are more costly.

17 Aug 2022

UC San Diego receives $1.3 million grant to understand the role of misfolded tau proteins in dementia

Researchers at the University of California San Diego have received a $1.3 million grant from the W. M. Keck Foundation for a project that could help scientists better understand the role misfolded tau proteins play in causing neurodegenerative diseases like dementia, which may lead to more effective drug therapies.

16 Aug 2022

Alzheimer's Disease News and Research

Further Reading

Penn State receives $1.6 million grant to study the link between COVID-19 and cognitive decline

UC Davis research reveals a novel role for how tau functions in healthy nerve cells

Study investigates associations between MS prevalence and factors driving regional differences

Changes in brain connections occur very early in Alzheimer's disease

Study analyzes associations between BMI and dementia in older women and men

Simple blood test can accurately detect Alzheimer's disease in people with Down syndrome

Study provides evidence of a new form of dementia affecting WTC responders

Brain cells with the same birthdate show distinct connectivity and activity, study finds

Sanders-Brown director receives $1.5 million grant to advance research on Alzheimer's treatment

Increasing the production of new neurons rescues memory defects in mice with Alzheimer's disease

Alzheimer's disease disrupts visual memory by degrading cross-hemispheric cells

Combination of new testing methods helps identify multiple dementia risk genes

Therapeutic target for several metabolic diseases may help fight Alzheimer’s disease

Women with epilepsy have more depression and anxiety symptoms during pregnancy and postpartum

Study reveals a mechanism linking DDT exposure to Alzheimer's disease

Expert panel identifies critical challenges in recruiting study participants

UC San Diego receives $1.3 million grant to understand the role of misfolded tau proteins in dementia

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

Peter Adams and Bing Ren receive NIH grant to join multi-institution initiative studying the aging process

Older heart muscle cells accumulate new genetic mutations -; while losing the ability to repair them

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News